News

The U.S. Food and Drug Administration (FDA) has released a draft Compliance Policy Guide (CPG) relating to the enforcement policy for labelling major food allergens, including allergens that are unintentionally present. The draft CPG reflects the FDA’s updated thinking based…

There were 29 food recalls in Australia due to undeclared allergens in 2022, marking a 23 per cent decrease from the previous year and the lowest number recorded since 2015. Despite this drop, undeclared allergens remain the primary cause of…

Lawmakers in the United States have proposed a new Food Labelling Modernization Act of 2023, saying “Consumers deserve straightforward, easily accessible information about the ingredients and nutritional value of products they want to buy. With front of package labels, clearly…

Allergen and gluten analysis is an essential part of food safety management. It involves identifying the presence and level of allergens or gluten in food products to ensure that they are safe for consumption by individuals with food allergies or…

Philip Hill, General Manager of r-biopharm Australia is delighted to confirm their long standing partnership with FAMS and once again take the platinum sponsorship position at the 2023 symposium, an association they are proud to have had since the inception of FAMS.…

Did you know that our Director Jasmine Lacis-Lee together with Dr Simon Brooke-Taylor and Allergen Bureau manager Lisa Clark have published ‘Allergens as a Food Safety Hazard: Identifying and Communicating the Risk’ as one of the stand-alone chapters published online…